Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-080750
Filing Date
2025-08-26
Accepted
2025-08-26 16:05:31
Documents
1
Period of Report
2025-08-26

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0254656-6k_universe.htm 6-K 9593
  Complete submission text file 0001213900-25-080750.txt   10730
Mailing Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100
Business Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100 86-0796-8403309
Universe Pharmaceuticals INC (Filer) CIK: 0001809616 (see all company filings)

EIN.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-40231 | Film No.: 251257608
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)